StemRIM (TSE:4599) Net Margin %: 0.00% (As of Jan. 2026)


TSE:4599 StemRIM Inc TSE:4599
31 GF Score
Price 円313.00
! 2 Warning Signs
View Full Analysis

What is StemRIM Net Margin %?

StemRIM TSE:4599 +0.64% 31 Net Margin % is 0.00% as of Jan. 2026. GuruFocus rates TSE:4599 with a GF Score™ of 31/100. The stock has 2 warning signs investors should review. Among 946 Biotechnology companies, StemRIM ranks worse than 105708.14% on this metric.

Net margin is calculated as Net Income divided by its Revenue. StemRIM's Net Income for the six months ended in Jan. 2026 was 円-928.64 Mil. StemRIM's Revenue for the six months ended in Jan. 2026 was 円0.00 Mil. Therefore, StemRIM's net margin for the quarter that ended in Jan. 2026 was 0.00%.

The historical rank and industry rank for StemRIM's Net Margin % or its related term are showing as below:


TSE:4599's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -88.815
* Ranked among companies with meaningful Net Margin % only.

StemRIM  (TSE:4599) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

StemRIM Net Margin % Related Terms

StemRIM Net Margin % Historical Data

* Premium members only.

The historical data trend for StemRIM's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

StemRIM Net Margin % Chart

StemRIM Annual Data
Trend Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Net Margin %
Get a 7-Day Free Trial Premium Member Only -41.60 -8,479.75 7.16 0.00 0.00

StemRIM Semi-Annual Data
Jul17 Jul18 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Jul25 Jan26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

TSE:4599 vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, StemRIM's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

StemRIM Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, StemRIM's Net Margin % distribution charts can be found below:

* The bar in red indicates where StemRIM's Net Margin % falls into.


TSE:4599
31GF Score
StemRIM Inc TSE:4599
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

StemRIM Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

StemRIM's Net Margin for the fiscal year that ended in Jul. 2025 is calculated as

Net Margin=Net Income (A: Jul. 2025 )/Revenue (A: Jul. 2025 )
=-1929.437/0
= %

StemRIM's Net Margin for the quarter that ended in Jan. 2026 is calculated as

Net Margin=Net Income (Q: Jan. 2026 )/Revenue (Q: Jan. 2026 )
=-928.638/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
StemRIM (TSE:4599) has a Net Margin % of 0.00% as of Jan. 2026. Net margin is the ratio of total net income to net sales. View historical data on StemRIM and its competitors. According to the industry distribution chart, StemRIM ranks #999999 out of 946 companies in the Biotechnology industry.
Is StemRIM's Net Margin % too high?
StemRIM's current Net Margin % is 0.00%. Based on the distribution chart, StemRIM ranks #999999 out of 946 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, StemRIM has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does StemRIM's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, StemRIM ranks #999999 out of 946 companies for Net Margin %. This places StemRIM in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on StemRIM and its competitors. StemRIM's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is StemRIM stock overvalued right now?
StemRIM (TSE:4599) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. StemRIM's overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For StemRIM (TSE:4599), the current Net Margin % is 0.00% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

StemRIM Business Description

Address 7-15 Ayato Bio Incubator 3rd floor, Ayato Asagi 7-chome, Prefecture Ibaraki City, Osaka, JPN, 567-0085
StemRIM Inc is a biotechnology company engaged in developing regeneration-guided medicines. The business activity of the group includes research, development, manufacture, and sales of pharmaceuticals and medical devices and products such as gene therapy that activate stem cells existing in the body and induce regeneration of damaged tissue.
31GF Score

Get the complete analysis for TSE:4599

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円313.00
Price